Daan Gene Co., Ltd.

SZSE:002030.SZ

9.48 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001
Revenue 1,171.11512,046.1357,664.2625,341.211,098.2171,478.6631,542.4291,612.561,474.3391,086.153854.372582.692457.56369.968319.601239.204207.276172.539162.472155.862132.49102.15572.083
Cost of Revenue 737.6893,271.5351,934.0791,561.728551.074863.367877.02912.261919.512631.274436.395259.832204.336152.877133.29286.94983.12673.69971.52371.98573.62661.72244.09
Gross Profit 433.4268,774.65,730.1833,779.482547.143615.296665.409700.299554.827454.88417.977322.861253.224217.091186.309152.255124.1598.8490.94983.87758.86440.43327.993
Gross Profit Ratio 0.370.7280.7480.7080.4980.4160.4310.4340.3760.4190.4890.5540.5530.5870.5830.6370.5990.5730.560.5380.4440.3960.388
Reseach & Development Expenses 189.061702.404508.802166.94794.91486.12894.25916.07721.370.33353.51358.0300012.6960000000
General & Administrative Expenses 38.2926.758113.65546.19123.44271.139117.90896.12568.31663.58462.80469.28437.16830.43581.68218.35540.39732.03329.39921.50818.46311.2528.185
Selling & Marketing Expenses 172.833939.512790.207666.96194.007208.166274.591289.092230.631169.265162.556132.83590.96768.47952.96352.73937.19832.02427.36829.7227.632.2061.031
SG&A 414.686966.27903.862713.151217.448279.304392.498385.218298.947232.849225.361202.119128.13498.915134.64571.09477.59464.05756.76751.2326.09313.4579.216
Other Expenses -191.36266.258180.907173.60234.06489.2351.06751.80750.71423.13119.23112.90728.03927.4615.72413.5053.3821.4730.016-0.0140.1611.554-0.318
Operating Expenses 795.1081,934.9321,593.5721,053.7346.426454.667518.577554.294437.546339.325319.942285.7198.987168.52139.16117.40281.34964.31760.10351.629.30316.8569.792
Operating Income -361.6816,329.2544,125.3972,940.089295.305212.992110.878101.00587.035172.91152.45680.75250.85142.50541.66834.47739.67834.94832.22430.06227.47421.99917.262
Operating Income Ratio -0.3090.5250.5380.550.2690.1440.0720.0630.0590.1590.1780.1390.1110.1150.130.1440.1910.2030.1980.1930.2070.2150.239
Total Other Income Expenses Net 521.318-10.318-5.316-37.223-289.255-111.166-34.8876.00319.34380.3673.30156.41224.61821.30410.18413.0480.1571.8451.256-2.229-1.925-1.604-1.256
Income Before Tax 159.6376,318.9374,120.0812,902.8666.05101.825111.945152.009136.624195.915171.33793.57378.85569.87557.33347.90142.95836.39432.17130.04827.63521.97416.944
Income Before Tax Ratio 0.1360.5250.5380.5430.0060.0690.0730.0940.0930.180.2010.1610.1720.1890.1790.20.2070.2110.1980.1930.2090.2150.235
Income Tax Expense 41.804891.378501.595452.82153.2115.31415.82516.09618.87237.29434.3567.59811.60311.5679.5378.2758.7548.2085.844.9154.5933.4512.845
Net Income 104.665,412.3413,618.1872,449.09-47.159101.58386.448106.686101.237153.056133.27590.16568.01156.45347.35639.10835.03628.07726.29725.223.09318.56514.088
Net Income Ratio 0.0890.4490.4720.459-0.0430.0690.0560.0660.0690.1410.1560.1550.1490.1530.1480.1630.1690.1630.1620.1620.1740.1820.195
EPS 0.0753.862.581.75-0.0340.0720.0630.0780.0720.110.10.0650.0470.040.0330.0310.0290.0250.0230.0220.0270.0290.029
EPS Diluted 0.0753.862.581.75-0.0340.0720.0630.0780.0720.110.10.0650.0470.040.0330.0310.0290.0250.0230.0220.0270.0290.029
EBITDA 3.5967,605.3734,498.8213,190.978371.027300.564264.288288.676232.77268.135224.243141.699124.645108.51794.28886.31574.09460.49363.25861.53854.75642.54418.333
EBITDA Ratio 0.0030.6310.5870.5970.3380.2030.1710.1790.1580.2470.2620.2430.2720.2930.2950.3610.3570.3510.3890.3950.4130.4160.254